图书简介
The Oxford Textbook of Rheumatoid Arthritis covers all relevant aspects of the fisease, ranging from basic science, epidemiology, clinical and laboratory assessments, drug and non-drug treatments, and disease outcomes. Written by an international team of experts, it will be an invaluable resource for those involved with people with RA.
1. History, diagnosis, and epidemiology; 1 David L. Scott: The history of rheumatoid arthritis; 2 Daniel Aletaha and Helga Radner: Diagnosis; 3 James Gwinnutt and Deborah Symmons: The descriptive epidemiology of rheumatoid arthritis; 4 Lars Klareskog and Lars Alfredsson: Modifiable and other risk factors for rheumatoid arthritis: a basis for prevention and better therapy; 2. Pathogenesis; 5 Anne Barton: Genetics and epigenetics of rheumatoid arthritis; 6 Thomas Crowley, Jason Turner, Andrew Filer, Andy Clark, and Chris Buckley: Dysregulation of synovial fibroblasts in rheumatoid arthritis; 7 Tom W. J. Huizinga: Autoantibodies in rheumatoid arthritis; 8 Soi-Cheng Law, Pascale Wehr, Harriet Purvis, and Ranjeny Thomas: Dendritic cells and T cells in rheumatoid arthritis; 9 Ukrike Steffen and Georg Schett: Mechanisms of bone and cartilage destruction; 10 Marina Frleta-Gilchrist and Iain B. McInnes: Cytokines and other mediators; 3. Clinical presentation; 11 Annette van der Helm-van Mil: Clinical features of rheumatoid arthritis; 12 Karim Raza, Catherine McGrath, Laurette van Boheemen, and Dirkjan van Schaardenburg: Pre-rheumatoid arthritis; 13 Katherine MacDonald, Jennifer Hannah, and James Galloway: Non-articular manifestations of rheumatoid arthritis; 14 Kimme Hyrich and Sarah Skeoch: Comorbidity in rheumatoid arthritis; 4. Disease assessment; 15 Josef Smolen: Disease activity assessment in rheumatoid arthritis; 16 Douglas Veale and Ursula Fearon: Synovial biopsies; 17 Charles Peterfy, Philip Conaghan, and Mikkel Ostergaard: Radiography in rheumatoid arthritis; 18 Andrew Filer, Maria Antonietta D’Agostino, and Ilfita Sahbudin: Ultrasound in rheumatoid arthritis; 19 Charles Peterfy, Philip Conaghan, and Mikkel Ostergaard: MRI in rheumatoid arthritis; 5. Impact on life; 20 Kathryn A. Gibson and Theodore Pincus: Patient physical function in rheumatoid arthritis; 21 Emma Dures and Neil Basu: Fatigue; 22 David L. Scott and Allan Wailoo: Health economics; 23 Suzanne Verstappen, Cheryl Jones, Abdullah Houssien, and James Galloway: Rheumatoid arthritis and work; 6. Non-drug treatments; 24 Lindsay Bearne and Christina Opava: Exercise; 25 Heidi Siddle and Anthony Redmond: Foot health; 26 Alison Hammond, Joanne Adams, and Yeliz Prior: Occupational therapy; 27 Marieke M.J.H. Voshaar: Self-management: a patient’s perspective; 7. Drug treatments; 28 Mark D Russell and Nidhi Sofat: Analgesics, Opioids, and NSAIDs; 29 Johannes W. G. Jacobs, Marlies C. van der Goes, Johannes W. J. Bijlsma, and Jose A. P. da Silva: Glucocorticoids; 30 David L. Scott: Conventional disease modifying drugs; 31 Peter Taylor and Nehal Narayan: Tumour necrosis factor inhibitors; 32 Neelam Hassan and Ernest Choy: Interleukin-6 inhibitors; 33 Yuzaiful Yusof, Edward Vital, and Maya Buch: B-cell therapies; 34 Vibeke Strand, Jeffrey Kaine, and John Isaacs: Biosimilars; 35 Meghna Jani, John Isaacs, and Vibeke Strand: Immunogenicity in response to biologic agents; 36 Katie Bechman, James Galloway, and Peter Taylor: The use of JAK inhibitors in the treatment of rheumatoid arthritis; 37 Ben G.T. Coumbe, Elena Nikiphorou, and Tuulikki Sokka-Isler: Combination therapy in rheumatoid arthritis; 38 Jeremy Sokolove: Translation of new therapies: from bench to bedside; 39 James Galloway and Mark Yates: Adverse events in clinical studies in rheumatoid arthritis; 8. Management and outcomes; 40 Tom W. J. Huizinga, Annette van der Helm-van Mil, and Andrew Cope: Prevention of rheumatoid arthritis; 41 Kenneth F Baker and Arthur G Pratt: Treatment targets and remission; 42 David L. Scott: Clinical outcomes; 43 Anna-Birgitte Aga, Espen A. Haavardsholm, Till Uhlig, and Tore K. Kvien: Clinical guidelines; 44 Angela Zink and Anja Strangfeld: European biologics registers; 45 Jeff Greenberg and Sheetal Patel: Voluntary patient registries
Trade Policy 买家须知
- 关于产品:
- ● 正版保障:本网站隶属于中国国际图书贸易集团公司,确保所有图书都是100%正版。
- ● 环保纸张:进口图书大多使用的都是环保轻型张,颜色偏黄,重量比较轻。
- ● 毛边版:即书翻页的地方,故意做成了参差不齐的样子,一般为精装版,更具收藏价值。
关于退换货:
- 由于预订产品的特殊性,采购订单正式发订后,买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性,发生以下情况的,请直接拒收货物,由快递返回:
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全(例如:光盘等)
并请在工作日通过电话400-008-1110联系我们。
- 签收后,如发生以下情况,请在签收后的5个工作日内联系客服办理退换货:
- ● 缺页/错页/错印/脱线
关于发货时间:
- 一般情况下:
- ●【现货】 下单后48小时内由北京(库房)发出快递。
- ●【预订】【预售】下单后国外发货,到货时间预计5-8周左右,店铺默认中通快递,如需顺丰快递邮费到付。
- ● 需要开具发票的客户,发货时间可能在上述基础上再延后1-2个工作日(紧急发票需求,请联系010-68433105/3213);
- ● 如遇其他特殊原因,对发货时间有影响的,我们会第一时间在网站公告,敬请留意。
关于到货时间:
- 由于进口图书入境入库后,都是委托第三方快递发货,所以我们只能保证在规定时间内发出,但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间:
- 010-68433105/3213正常接听咨询电话的时间为:周一至周五上午8:30~下午5:00,周六、日及法定节假日休息,将无法接听来电,敬请谅解。
- 其它时间您也可以通过邮件联系我们:customer@readgo.cn,工作日会优先处理。
关于快递:
- ● 已付款订单:主要由中通、宅急送负责派送,订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐